Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

EU regulator approves Moderna vaccine as fears grow over virus variants

by AIP Online Bureau | Jan 6, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic

  AMSTERDAM: Europe’s drug regulator gave the green light to Moderna Inc’s COVID-19 vaccine on Wednesday, the second shot it has approved, as authorities accelerate inoculation efforts amid fears about more infectious variants of the...

Health min warns people against fake Co-WIN apps, says govt-approved app will be launched soon

by AIP Online Bureau | Jan 6, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

  New Delhi: The Union Health Ministry on Wednesday cautioned people against downloading and sharing personal information on some apps named Co-WIN, ''created by unscrupulous elements'', that sound similar to the upcoming official platform of the...

Peruvian minister raises ‘controversy’ over Pfizer vaccine liability clause

by AIP Online Bureau | Jan 6, 2021 | Eco/Invest/Demography, Health, International News, Pandemic, Risk Management

  LIMA: Peru’s health minister said on Tuesday that “controversy” had arisen over a liability waiver in the country’s negotiations to obtain COVID-19 vaccines from Pfizer Inc.Pilar Mazzetti told Congress that Peruvian officials had been in...

Criticism mounts over India’s ‘abrupt’ approval of COVAXIN

by AIP Online Bureau | Jan 6, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

BENGALURU: Criticism of India’s approval of a local COVID-19 vaccine without proof of its efficacy grew on Wednesday after news that a regulatory panel approved the shot just one day after asking the vaccine maker for more evidence it would work.The...

All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary

by AIP Online Bureau | Jan 6, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

  NEW DELHI: All Indian vaccines being developed against the coronavirus will have to be stored at 2-8 degrees Celsius as the logistics have been worked out while considering temperature as a factor, department of biotechnology secretary Renu Swarup said on...
« Older Entries
Next Entries »

Recent Posts

  • French riots seen as insurance test before new regime kicks in
  • Sanjay Lalla to head EASE project for PSU general insurers
  • CyberCube adds Sompo Japan Insurance to growing list of Asian clients
  • French violence raises alert as protests flare across Europe
  • AI agents can pose insider security risks even without being hacked: Microsoft

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy